ClavystBio
Overview
ClavystBio is a life sciences investor and venture builder established by Temasek to accelerate the commercialization of breakthrough ideas into health impact. We invest and partner with founders and …
Investment Focus
- Innovative biotech, medtech, and digital health solutions
- Strong founding teams with a clear vision
- Scalable business models with global potential
- Alignment with ClavystBio's mission to accelerate health impact
Portfolio Companies
Reach ClavystBio directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about ClavystBio
What sectors does ClavystBio invest in?
ClavystBio invests in Healthcare, Artificial Intelligence, Life Sciences, Digital Health, Medical Devices and Diagnostics, and is based in Science Park Drive, Singapore. ClavystBio is listed as a venture capital in the ConnectSafely investor database.
What stage does ClavystBio invest at?
ClavystBio backs companies at Pre-Seed, Seed, Series A and Growth, writing cheques of 2M - 20M.
Which regions does ClavystBio invest in?
ClavystBio invests across United States, Australia, Europe, Singapore, China and Netherlands.
Who are the partners at ClavystBio?
Team members listed for ClavystBio include Khoo Shih (Chief Executive Officer) and Yingmin Wang (Director, Digital Health & Medtech Investments).
What companies has ClavystBio invested in?
ClavystBio's portfolio includes Respiree, Hummingbird Bioscience Pte. Ltd., Paratus Sciences Corp., CoVBio, Leyden Labs Asia and 65LAB.
How do I contact ClavystBio?
ClavystBio's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database